focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.
News will follow and it will be positive but in the meantime, the game that is AIM will continue. As a holder for 4 months, I'm seen all the ups and downs.
The lack of news is IMHO good, it means RM and his team are very busy evaluating all the options and no doubt offers that are on the table.
In Covid and COPD, Synairgen has in effect two significant opportunities to address. I'd love to be a fly on the wall but the RM wry smile in his recent video told me they're all good convos.
This share is such a strong buy or hold.
The roulette was spun ages ago. IMHO RM and Synairgen removed all of the risk with the Covid RNS back July and the COPD one more recently. We have double protection. If Covid goes away (which the data says it won't) then we have COPD.
We have good data and SNG001 works for both plus it works with Steroids. We just have to have some patence and suffocate the derampers by not commenting on their posts.
The data shows that's this pandemic is anything but over and worryingly could be just getting started. Sadly for Europe and the Northern Hemisphere the data shows that it's heading into the Autumn/Winter season with a very strong tailwind.
SP currently 187.50 with a sell at 185 and buy at 190 (spread of 5) yet I can sell a 10k shareholding on HL at 189.5111
More background buying for someone?
Proper games utilising the spread to keep SP depressed?
Thoughts?
More references to pregnancy style test, supported by PM. Technology not proved but very close. He discussed the cost benefit of this type of programme that accelerates the country back to some form of normality.
Salford is likely linked with CONDOR as part of the programme is based in Manchester and Salford
Watch PMQs in full: Boris Johnson discusses the UK future testing vision.
https://youtu.be/1NCJ9n4aLdU
Head to 7mins 15 seconds
@MrIndia not sure about others but Avacta have something but it's very early days https://avacta.com/update-on-affimer-therapy-for-covid-19-infection/
Via Twitter word is that the "unexpected adverse reaction in a participant of the Vaccine" is a UK female hospitalized with transverse myelitis that includes loss of use of her hands & feet.
Transverse myelitisan is an inflammatory syndrome that affects the spinal cord & is often sparked by viral infections.
Just awful news for the lady and her family, I hope she recovers her full health.